Our reimbursement resources are designed to help you with important reimbursement issues and questions.

You can find answers to your ORTHOVISC reimbursement questions by visiting the ORTHOVISC®Line website or contacting our support hotline.
ORTHOVISC® is eligible for reimbursement by Medicare and most managed care plans. Depending upon reimbursement coverage, ORTHOVISC® can be obtained by purchasing directly from DePuy Mitek Customer Service at 1-800-382-4682 or writing an ORTHOVISC® prescription.
Insurance policies and coverage for ORTHOVISC® vary patient-to-patient and plan-to-plan. It is recommended to check with a specific patient insurance carrier to verify coverage.
ORTHOVISC® offers a Patient Assistance Program through Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF), an independent, non-profit organization. JJPAF provides assistance to patients experiencing financial hardship who have no insurance coverage for their prescription medicines. To learn more about JJPAF, visit, www.jjpaf.org or call 800-652-6227.
ORTHOVISC®Line has an online reimbursement support center to provide physicians and their office staff assistance with reimbursement for ORTHOVISC® High Molecular Weight Hyaluronan.
go to the ORTHOVISC® support center
Reimbursement rates for ORTHOVISC®, as well as other competitive hyaluronic acid products, change quarterly and are updated by Centers for Medicare and Medicaid (CMS).
The following codes are used for ORTHOVISC® Reimbursement for both Medicare and Private Pay Insurance Claims. We encourage you to contact your local Medicare or Private Pay Insurance Carriers to understand the recommended coding for ORTHOVISC®. In addition, ORTHOVISC®Line, 1-866-633-VISC (8472) can serve as a resource to identify codes.
| product name | generic name | national drug code | dose |
|---|---|---|---|
| ORTHOVISC® | High molecular weight hyaluronan | 59676-0360-01 | 30 mg injection |
HCPCS code menu
| J 7324 | ORTHOVISC® Injection |
diagnosis code menu (ICD-9) Diagnosis codes should be included in Box 21 of the CMS 1500 Form.
| 715.16 | Osteoarthritis, localized, primary (lower leg) |
| 715.26 | Osteoarthritis, localized, secondary (lower leg) |
| 715.36 | Osteoarthritis, localized, not specific whether primary or secondary (lower leg) |
| 715.96 | Osteoarthritis, unspecified whether generalized or localized, multiple sites |
CPT code CPT Codes should be billed on the same claim as ORTHOVISC® to describe the method of administration. The CPT code should be included in Box 24D of the CMS 1500 claim form. An example CPT Code is:
| 20610 | Arthrocentesis, aspiration and/or injection; major joint or bursa (e.g., shoulder, hip, knee joint, subacromial bursa) |
modifier menu Several modifiers may be relevant when billing ORTHOVISC®. Modifiers should be included in Box 24D of the CMS 1500 claim form. Possible modifiers include:
| 25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service |
| 50 | Bilateral procedure |
| RT | Right side (used to identify procedures performed on the right side of the body) |
| LT | Left side (used to identify procedures performed on the left side of the body) |
| EJ | Subsequent claims for a defined course of therapy |
Hospitals use a CMS-1450 or UB-04 claim form. Coding for hospital outpatient is the same as in the physician office, J 7324 - ORTHOVISC, CPT Code 20610, ICD-9 Code 715.16, 715.26, 715.36 and 715.96. Medicare reimbursement for hospital inpatient is based on DRGs.
| *HCPCS J Code Description | **Q4 2010 Reimbursement Rate |
| ORTHOVISC®-J7324 (Sodium Hyaluronate per 30mg for intraarticular injection) | $169.335 |
| Hyalgan™-J7321 (Sodium Hyaluronate per 20 to 25mg dose for intraarticular injection) | $89.695 |
| Supartz™-J7321 (Sodium Hyaluronate per 20 to 25mg dose for intraarticular injection) | $89.695 |
| Euflexxa™ -J7323 (Sodium Hyaluronate per 20mg dose for intraarticular injection) | $148.905 |
| Synvisc™ and Synvisc One™ -J7325 (Hyaluronan or derivative, Synvisc or Synvisc-one, for intra-articular injection, 1 mg ) | $12.155/mg |
* New HCPCS J Code -Federal Register/Vol. 72, No. 227, pp 66774 / Nov. 27, 2007 **
www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/
01a19_2010aspfiles.asp#TopOfPage
THE INFORMATION PROVIDED REPRESENTS NO STATEMENT, PROMISE, OR GUARANTEE BY DEPUY MITEK CONCERNING COVERAGE, LEVELS OF REIMBURSEMENT, PAYMENT, OR CHARGE. PLEASE CONSULT YOUR PAYOR ORGANIZATION WITH REGARD TO LOCAL OR ACTUAL COVERAGE AND REIMBURSEMENT POLICIES AND DETERMINATION PROCESSES.
Proper coding and billing are critical steps to ensure prompt claim payment. Codes for ORTHOVISC® can be found on claims code page. Below are several examples of HCFA 1500 Claim Forms for ORTHOVISC®. A common error that may lead to claim denial is submitting an incomplete claim form.
ORTHOVISC® is reimbursed under J 7324. Medicare and Private Pay plans vary in relation to J 7324 for ORTHOVISC®. We encourage you to contact your local Medicare or Private Pay Insurance Carriers to verify patient specific coverage. In addition, ORTHOVISC®Line, 1-866-633-VISC (8472) can serve as a resource to identify codes.
example 1 – Initial visit with decision to start ORTHOVISC®
example 2 – Return visit for 2nd and 3rd injection
example 3 – Follow-up injection with exam for separate condition
example 4 – Bilateral injections
You may find these forms helpful for your patients, in addition to information they can learn from calling the ORTHOVISCLine or visiting the support center.
Benefits verification and patient authorization form
ORTHOVISC®Line
Phone: 1-866-633-VISC (8472)
Fax: 1-877-248-1182
Available Monday–Friday, 9AM–8PM ET
©DePuy Companies 2012. All Rights Reserved. This site is published by the DePuy Companies, which are solely responsible for its content.
This site is governed solely by applicable U.S. laws and governmental regulations.
